Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- GRAY
- Price
- -
- Stock movement down
- -0.05 (-1.67%)
- Company name
- Graybug Vision Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 64.89M
- Ent value
- 53.16M
- Price/Sales
- 12.02
- Price/Book
- 2.95
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -76.61%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
GRAY does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 12.02 |
| Price to Book | 2.95 |
| EV to Sales | 9.85 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 22.00M |
| EPS (TTM) | -46.15 |
| FCF per share (TTM) | -28.42 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 5.40M |
| Gross profit (TTM) | 5.40M |
| Operating income (TTM) | -48.34M |
| Net income (TTM) | -37.98M |
| EPS (TTM) | -46.15 |
| EPS (1y forward) | -1.66 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -895.44% |
| Profit margin (TTM) | -703.67% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 24.39M |
| Net receivables | 0.00 |
| Total current assets | 34.50M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 34.67M |
| Accounts payable | 2.06M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 12.65M |
| Total liabilities | 12.65M |
| Shareholder's equity | 22.02M |
| Net tangible assets | 22.02M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -21.71M |
| Capital expenditures (TTM) | 529.00K |
| Free cash flow (TTM) | -23.39M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -172.51% |
| Return on Assets | -109.56% |
| Return on Invested Capital | -172.51% |
| Cash Return on Invested Capital | -106.25% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| GRAY | S&P500 | |
| Current price drop from All-time high | -99.40% | -12.33% |
| Highest price drop | -99.56% | -56.47% |
| Date of highest drop | 13 Apr 2023 | 9 Mar 2009 |
| Avg drop from high | -81.32% | -11.07% |
| Avg time to new high | 67 days | 12 days |
| Max time to new high | 587 days | 1805 days |
COMPANY DETAILS
Marketcap
64.89M
Marketcap category
Small-cap
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
Employees
8
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner